• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CynergisTek Reports Improved Second Quarter 2021 Financial Results

    8/16/21 4:05:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $CTEK alert in real time by email

    CynergisTek, Inc. (NYSE:CTEK), a leader in cybersecurity, privacy, and compliance, today announced financial results for the three and six months ended June 30, 2021.

    Q2 2021 Operational Highlights

    • First Authorized Certified Third-Party Assessor Organization approved to provide CMMC assessments. CynergisTek also recently certified as a Licensed Training Provider.
    • CynergisTek's revenue pipeline strengthened with bookings increasing 70% over prior year and 24% sequentially
    • Gross margin improved to 33% from cost reduction initiatives (46% including benefit of the Employee Retention Tax Credit).
    • Net loss improved year over year to $0.1 million ($0.00 per share) from $2.5 million ($0.23 per share).
    • Adjusted EBITDA improved to a loss of $0.6 million from $1.3 million.

    "Looking ahead, the Cynergistek team is squarely focused on growth, building on our position as the trusted healthcare partner, and expanding the addressable market for our cybersecurity services. We are rebuilding our revenue pipeline with our sales team back at full strength and healthcare providers beginning to return to more normal buying patterns to address critical cyber concerns that have been deferred during Covid. We also have a first-mover advantage with our recent approvals in CMMC, significantly expanding our potential addressable market," said Mac McMillan, President and CEO of CynergisTek, Inc.

    "The recent wins with larger healthcare and university customers, as well as a pipeline that is expanding to include additional large institutions and Fortune 500 companies, are key indicators of our progress. We also have several small wins related to CMMC assessments, with such wins poised to expand as the Department of Defense begins to require assessments for all vendors."

    For the Three Months Ended June 30, 2021, as Compared to the Three Months Ended June 30, 2020

    Revenue was $3.9 million for the three months ended June 30, 2021, as compared to $4.6 million for the same period in 2020. Managed Services revenue decreased for the three months ended June 30, 2021, by $0.8 million to $2.2 million, due to the impact of some customers canceling or delaying renewals largely because of the impact from COVID-19. Consulting and professional services revenue was $1.7 million for the three months ended June 30, 2021, as compared to $1.6 million for the same period in 2020, due to the start of a rebound in our healthcare cybersecurity business.

    Gross margin was 46% of revenue due in part to the positive impact of the Employee Retention Tax Credit. Excluding the Employee Retention Tax Credit, gross margin was 33% for the three months ended June 30, 2021, as compared to 27% for the same period in 2020. This increase was a direct result of expense reductions and operational efficiencies.

    SG&A expenses decreased for the three months ended June 30, 2021 by $0.8 million to $2.7 million, as compared to the same period in 2020, primarily due to a $0.6 million reduction in payroll and benefit costs because of headcount reductions, decreases in travel because of COVID-19, and a $0.2 million benefit from the Employee Retention Tax Credit.

    GAAP net loss for the three months ended June 30, 2021, was $0.1 million, or $0.00 per basic and diluted share, as compared to a net loss of $2.5 million, or $0.23 per basic and diluted share, for the same period of 2020.

    Non-GAAP adjusted EBITDA loss was $0.6 million for the three months ended June 30, 2021, compared to a loss of $1.3 million for the same period in 2020.

    The reconciliation of GAAP to non-GAAP information can be found in the table at the end of this release, which provides the details of CynergisTek, Inc.'s non-GAAP disclosures and the reconciliation of non-GAAP information.

    Use of Non-GAAP Measures

    CynergisTek, Inc. ("CynergisTek" or the "Company") prepares its consolidated financial statements in accordance with generally accepted accounting principles ("GAAP"). In addition to disclosing financial results prepared in accordance with GAAP, the Company discloses information regarding Adjusted EBITDA ("Adjusted EBITDA"), which differs from the commonly-used "EBITDA." In addition to adjusting net income (loss) to exclude income taxes, interest, depreciation, and amortization, Adjusted EBITDA also excludes share-based compensation, impairment charges, fair value adjustments, severance, and other cash and non-cash charges and gains.

    Adjusted EBITDA is not a measure of performance as defined in accordance with GAAP. However, Adjusted EBITDA is used internally in planning and evaluating the Company's operating performance. Accordingly, management believes that disclosure of this metric offers investors, bankers, and other stakeholders an additional view of the Company's operations that, when coupled with the GAAP results, provides a more complete understanding of the Company's financial results.

    Adjusted EBITDA should not be considered as an alternative to loss-from-continuing-operations or net-cash-used-in-operating-activities as measures of operating results or liquidity. The Company's calculation of Adjusted EBITDA may not be comparable to similarly titled measures used by other companies, and the measures exclude financial information that some may consider important in evaluating the Company's performance.

    Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of the Company's results as reported under GAAP. Some of these limitations are (i) it does not reflect the Company's cash expenditures, or future requirements for capital expenditures or contractual commitments, (ii) it does not reflect changes in, or cash requirements for, the Company's working capital needs, (iii) Adjusted EBITDA does not reflect interest expense, or the cash requirements necessary to service interest or principal payments, on the Company's debt, (iv) although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements, (v) it does not adjust for all non-cash income or expense items that are reflected in the Company's statements of cash flows, (vi) it does not reflect the impact of earnings or charges resulting from matters the Company considers not to be indicative of its ongoing operations, and (vii) other companies in the same industry may calculate this measure differently than the Company does, limiting its usefulness as a comparative measure.

    Management believes Adjusted EBITDA facilitates operating performance comparisons from period to period by isolating the effects of some items that vary from period to period without any correlation to core operating performance or that vary widely among similar companies. These potential differences may be caused by variations in capital structures (affecting interest expense), tax positions (such as the impact on periods or companies of changes in effective tax rates or net operating losses) and the age and book depreciation of facilities and equipment (affecting relative depreciation expense). Management also presents Adjusted EBITDA because (i) management believes this measure is frequently used by securities analysts, investors and other interested parties to evaluate companies in the same industry, (ii) management believes investors will find this measure useful in assessing the Company's ability to service or incur indebtedness, and (iii) management uses Adjusted EBITDA internally as a benchmark to evaluate the Company's operating performance or compare the Company's performance to that of its competitors.

    Conference Call Information

    Date: Monday August 16, 2021

    Time: 4:30 pm ET / 1:30 pm PT

    U.S.: 1-866-269-4262

    International: 1-786-204-3977

    Conference ID: 1559900

    Webcast: http://public.viavid.com/index.php?id=146073

    A replay of the call will be available from Monday August 16, 2021, 7:30 PM ET to Monday August 23, 2021, 11:59 PM ET. To access the replay, please dial 1-844-512-2921 if from the U.S. or 1-412-317-6671 if from outside the U.S. The PIN is 1559900.

    About CynergisTek, Inc.

    CynergisTek is a top-ranked cybersecurity consulting firm helping organizations in highly-regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company's security posture and ensure that the company's team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit www.cynergistek.com or follow us on Twitter or Linkedin.

    Cautionary Note Regarding Forward Looking Statements

    This release contains certain forward-looking statements relating to the business of CynergisTek. These forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and can be identified by the use of forward-looking terminology such as "believes," "expects," "anticipates," "would," "could," "intends," "may," "will," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including but not limited to uncertainties relating to product/services development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other providers; the ability of the Company's vendors to continue supplying the Company with supplies and services at comparable terms and prices; the Company's ability to successfully compete and introduce enhancements and new features that achieve market acceptance and that keep pace with technological developments; the Company's ability to maintain its brand and reputation and retain or replace its significant customers; cybersecurity risks and risks of damage and interruptions of information technology systems; the Company's ability to retain key members of management and successfully integrate new executives; the Company's ability to complete acquisitions, strategic investments, entry into new lines of business, divestitures, mergers or other transactions on acceptable terms, or at all; potential risks and uncertainties relating to the existing and ultimate impact of COVID-19, including the geographic spread, the severity of the virus, the duration of the COVID-19 outbreak, actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact, and the potential negative impacts of COVID-19 on the global economy and financial markets, and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in the Company's Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not now anticipated. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

    CYNERGISTEK, INC. AND SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS

     

     

    June 30, 2021

    (unaudited)

    December 31,

    2020

    ASSETS

     

     

    Current assets:

     

     

    Cash and cash equivalents

    $

    4,025,827

     

    $

    5,613,654

     

    Accounts receivable, net of allowance for doubtful accounts

     

    1,970,557

     

     

    2,063,136

     

    Unbilled services

     

    549,031

     

     

    566,713

     

    Prepaid and other current assets

     

    1,670,699

     

     

    2,032,420

     

    Income taxes receivable

     

    1,917,456

     

     

    1,680,866

     

    Total current assets

     

    10,133,570

     

     

    11,956,789

     

     

     

     

    Property and equipment, net

     

    301,324

     

     

    541,525

     

    Deposits

     

    47,376

     

     

    64,586

     

    Deferred income taxes

     

    5,025,545

     

     

    4,959,125

     

    Intangible assets, net

     

    5,382,561

     

     

    6,063,617

     

    Goodwill

     

    8,394,483

     

     

    8,394,483

     

    Total assets

    $

    29,284,859

     

    $

    31,980,125

     

    LIABILITIES AND STOCKHOLDERS' EQUITY

     

     

    Current liabilities:

     

     

    Accounts payable and accrued expenses

    $

    861,445

     

    $

    1,326,919

     

    Accrued compensation and benefits

     

    502,713

     

     

    814,830

     

    Deferred revenue

     

    1,525,021

     

     

    1,265,864

     

    Current portion of promissory note to related party

     

    421,875

     

     

    562,500

     

    Current portion of operating lease liability

     

    91,503

     

     

    252,398

     

    Total current liabilities

     

    3,402,557

     

     

    4,222,511

     

     

     

     

    Long-term liabilities:

     

     

    Earnout liability

     

    -

     

     

    1,300,000

     

    Promissory note to related party, less current portion

     

    -

     

     

    140,625

     

    Paycheck Protection Program loan

     

    2,825,500

     

     

    2,825,500

     

    Current portion of operating lease liability

     

    -

     

     

    40,031

     

    Total long-term liabilities

     

    2,825,500

     

     

    4,306,156

     

     

     

     

    Commitments and contingencies

     

     

    Stockholders' equity:

     

     

    Common stock, par value at $0.001, 33,333,333 shares authorized, 12,120,698 shares issued and outstanding at June 30, 2021, and 12,024,967 shares issued and outstanding at December 31, 2020

     

    12,120

     

     

    12,024

     

    Additional paid-in capital

     

    39,131,133

     

     

    38,564,520

     

    Accumulated deficit

     

    (16,086,451

    )

     

    (15,125,086

    )

    Total stockholders' equity

     

    23,056,802

     

     

    23,451,458

     

    Total liabilities and stockholders' equity

    $

    29,284,859

     

    $

    31,980,125

     

    CYNERGISTEK, INC. AND SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (UNAUDITED)

     

     

    Three Months Ended June 30,

    Six Months Ended June 30,

     

    2021

    2020

    2021

    2020

    Net revenues

    $

    3,875,143

     

    $

    4,557,571

     

    $

    8,048,664

     

    $

    9,673,398

     

    Cost of revenues

     

    2,083,056

     

     

    3,346,497

     

     

    4,173,890

     

     

    6,770,028

     

    Gross profit

     

    1,792,087

     

     

    1,211,074

     

     

    3,874,774

     

     

    2,903,370

     

     

     

     

     

     

    Operating expenses:

    Sales and marketing

     

    1,242,240

     

     

    1,677,484

     

     

    2,454,620

     

     

    3,164,831

     

    General and administrative

     

    1,470,593

     

     

    1,796,488

     

     

    3,147,251

     

     

    3,901,332

     

    Change in valuation of contingent earnout

     

    (1,300,000

    )

     

    -

     

     

    (1,300,000

    )

     

    -

     

    Depreciation

     

    48,186

     

     

    45,772

     

     

    95,882

     

     

    93,372

     

    Amortization of acquisition-related intangibles

     

    340,528

     

     

    416,191

     

     

    681,056

     

     

    832,382

     

    Finance cost for equity commitment

     

    -

     

     

    390,000

     

     

    -

     

     

    390,000

     

    Total operating expenses

     

    1,801,547

     

     

    4,325,935

     

     

    5,078,809

     

     

    8,381,917

     

    Loss from operations

     

    (9,460

    )

     

    (3,114,861

    )

     

    (1,204,035

    )

     

    (5,478,547

    )

     

     

     

     

     

    Other income (expense):

    Other income

     

    11

     

     

    -

     

     

    11

     

     

    -

     

    Interest income

     

    -

     

     

    1,608

     

     

    -

     

     

    7,675

     

    Interest expense

     

    (17,339

    )

     

    (27,320

    )

     

    (37,340

    )

     

    (51,607

    )

    Total other income (expense)

     

    (17,328

    )

     

    (25,712

    )

     

    (37,329

    )

     

    (43,932

    )

     

     

     

     

     

    Loss before provision for income taxes

     

    (26,788

    )

     

    (3,140,573

    )

     

    (1,241,364

    )

     

    (5,522,479

    )

    Income tax (expense) benefit

     

    (20,100

    )

     

    685,912

     

     

    279,999

     

     

    1,217,195

     

    Net loss

     

    (46,888

    )

     

    (2,454,661

    )

     

    (961,365

    )

     

    (4,305,284

    )

    Deemed dividends from warrant anti-dilution provision

     

    -

     

     

    -

     

     

    (5,834

    )

     

    -

     

    Net loss attributable to common shareholders

    $

    (46,888

    )

    $

    (2,454,661

    )

    $

    (967,199

    )

    $

    (4,305,284

    )

     

     

     

     

     

    Net loss per share:

     

     

     

     

    Basic

    $

    (0.00

    )

    $

    (0.23

    )

    $

    (0.08

    )

    $

    (0.41

    )

    Diluted

    $

    (0.00

    )

    $

    (0.23

    )

    $

    (0.08

    )

    $

    (0.41

    )

     

     

     

     

     

    Number of weighted average shares outstanding:

     

     

     

     

    Basic

     

    12,120,698

     

     

    10,495,700

     

     

    12,081,328

     

     

    10,432,443

     

    Diluted

     

    12,120,698

     

     

    10,495,700

     

     

    12,081,328

     

     

    10,432,443

     

    CYNERGISTEK, INC. AND SUBSIDIARIES

    RECONCILIATION OF GAAP LOSS FROM OPERATIONS TO NON-GAAP ADJUSTED EBITDA

    (UNAUDITED)

     

     

    Three Months Ended June 30,

     

    2021

     

    2020

    GAAP loss from operations

    $

    (9,460

    )

     

    $

    (3,114,861

    )

    Adjustments:

     

     

     

    Stock based compensation

     

    338,272

     

     

     

    606,265

     

    Change in valuation of contingent earnout

     

    (1,300,000

    )

     

     

    -

     

    Non-recurring restructuring and legal costs

     

    -

     

     

     

    350,000

     

    Depreciation

     

    48,186

     

     

     

    45,772

     

    Amortization of acquisition-related intangibles

     

    340,528

     

     

     

    416,191

     

    Finance cost for equity commitment

     

    -

     

     

     

    390,000

     

    Non-GAAP adjusted EBITDA

    $

    (582,474

    )

     

    $

    (1,306,633

    )

     

     

     

     

    Non-GAAP adjusted EBITDA per share:

     

     

     

    Basic

    $

    (0.05

    )

     

    $

    (0.12

    )

    Diluted

    $

    (0.05

    )

     

    $

    (0.12

    )

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005619/en/

    Get the next $CTEK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTEK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CTEK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Mcmillan Michael Henry returned 663,333 shares to the company, closing all direct ownership in the company

    4 - CYNERGISTEK, INC (0001011432) (Issuer)

    9/1/22 2:20:14 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4: Mccashin Robert gave a grant of 35,000 shares and returned 99,500 shares to the company, closing all direct ownership in the company

    4 - CYNERGISTEK, INC (0001011432) (Issuer)

    9/1/22 2:15:03 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4: Meadows Theresa Zak was granted 25,000 shares and returned 89,500 shares to the company, closing all direct ownership in the company

    4 - CYNERGISTEK, INC (0001011432) (Issuer)

    9/1/22 2:11:32 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CynergisTek Inc. Stockholders Approve Merger Agreement

    CynergisTek, Inc. (NYSE:CTEK), ("CynergisTek"), a leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, today announced that its stockholders have voted to approve the previously announced merger agreement dated May 23, 2022 ("Merger Agreement") with Clearwater Compliance LLC ("Clearwater"), a healthcare focused cybersecurity, compliance, and risk management solutions firm, and approval of the proposed merger contemplated by the Merger Agreement in an all cash transaction that values CynergisTek at approximately $17.7 million (the "Merger"). CynergisTek today held its virtual special

    8/31/22 4:50:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    DMG Announces Change of Directors

    VANCOUVER, British Columbia, Aug. 22, 2022 (GLOBE NEWSWIRE) -- DMG Blockchain Solutions Inc. (TSXV:DMGI) (OTC:DMGGF) (FRANKFURT: 6AX) ("DMG" or the "Company"), a vertically integrated blockchain and cryptocurrency technology company, announces John D. (J.D.) Abouchar has been appointed as a new independent Board Director and member of the Audit Committee. DMG also announces that independent Board Director, Nick Seto has resigned, effective August 22, 2022. Mr. Seto has served on DMG's board for three years and has stepped into a new consulting role for DMG. We thank him for his service since DMG's early days of mining. Mr. Abouchar brings a wealth of experience to the DMG board. He is th

    8/23/22 12:34:24 AM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    Global Healthcare Technology Leader Renews Multiple Contract Extensions Worth Over $300,000

    CynergisTek to provide its Data Privacy Compliance services to support ongoing data collection and processing activities CynergisTek, Inc. (NYSE:CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, announces a well-known medical device manufacturer is renewing multiple Data Privacy and Compliance contract extensions worth over $300,000. The globally recognized organization is extending its seven-year relationship with CynergisTek into 2023 to support its operations in 150 countries. CynergisTek is providing its long-standing client with robust Data Privacy Program Support se

    8/15/22 3:00:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    SEC Filings

    View All

    SEC Form EFFECT filed by CynergisTek Inc.

    EFFECT - CYNERGISTEK, INC (0001011432) (Filer)

    9/20/22 12:15:24 AM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 15-12G filed by CynergisTek Inc.

    15-12G - CYNERGISTEK, INC (0001011432) (Filer)

    9/13/22 3:53:45 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form S-8 POS filed by CynergisTek Inc.

    S-8 POS - CYNERGISTEK, INC (0001011432) (Filer)

    9/13/22 3:51:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    Leadership Updates

    Live Leadership Updates

    View All

    Tim McMullen Joins CynergisTek as Chief Operating Officer

    CynergisTek, Inc. (NYSE:CTEK), a leader in healthcare cybersecurity, privacy, and compliance, today announces the appointment of healthcare veteran, Tim McMullen, to the position of Chief Operating Officer. McMullen was most recently president of provider solutions at EMIDS Technology, a leading provider of digital transformation solutions to the healthcare industry, serving payers, providers, life sciences, and technology firms. "I am excited to join the CynergisTek team. What I found most compelling was the team's undisputed reputation in the healthcare cybersecurity, privacy, compliance, and IT audit space, and their recent leadership position providing Cybersecurity Maturity Model Cert

    10/13/21 1:00:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    CynergisTek Expands Expertise in Capital Markets, Investment Banking and Corporate Governance on its Board of Directors

    CynergisTek, Inc. (NYSE:CTEK), a leader in cybersecurity, privacy, and compliance, today announced that it has appointed John Flood to its board of directors. John was a founding partner of Craig-Hallum Capital Group ("Craig-Hallum"), an equity research, trading, and investment banking firm supporting the company's visibility in the public market, on their access to high-quality institutional investors, and their stock's liquidity and trading profile. At Craig-Hallum, Mr. Flood led the investment banking and institutional equity sales teams. He was also a member of the firm's board of governors, and executive, research, banking, and M&A committees. Mr. Flood will be added to the audit commi

    8/13/21 9:00:00 AM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    CynergisTek, Inc. Announces the Return of Mac McMillan as CEO and President to Lead Next Phase of Growth

    CynergisTek, Inc. (NYSE:CTEK), a leader in healthcare cybersecurity, privacy, and compliance, today announced the re-appointment of the Company's founder, Mac McMillan, to the positions of Chief Executive Officer and President effective immediately. Mr. Barlow will stay on for the next 30 days to support the transition. "I want to thank Caleb Barlow for his leadership through a very difficult period during the pandemic and his efforts to support our diversification strategy with CynergisTek being the first organization to successfully pass the Cybersecurity Maturity Model Certification (CMMC) Level 3 certification as an Authorized CMMC Third Party Assessor Organization (C3PAO). Caleb has p

    7/26/21 5:30:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CynergisTek Inc.

    SC 13G - CYNERGISTEK, INC (0001011432) (Subject)

    6/3/22 4:44:55 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form SC 13D/A filed by CynergisTek Inc. (Amendment)

    SC 13D/A - CYNERGISTEK, INC (0001011432) (Subject)

    6/1/22 1:13:47 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form SC 13G/A filed

    SC 13G/A - CYNERGISTEK, INC (0001011432) (Subject)

    2/16/21 11:25:43 AM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CTEK
    Financials

    Live finance-specific insights

    View All

    CynergisTek Files First Quarter 2022 Financial Results

    CynergisTek, Inc. (NYSE:CTEK) (the "Company" or "CynergisTek"), a leader in cybersecurity, privacy, and compliance, today announced financial results for the three months ended March 31, 2022. First Quarter Summary of Financial Results for Q1 2022 compared to Q1 2021: Revenue increases 12% to $4.7 million compared to $4.2 million. Gross margin improves to 40% compared to 38%, after adjusting Q1 2021 for the employee retention credits. Net loss was unchanged at $0.9 million. Adjusted EBITDA loss was unchanged at $0.6 million. First Quarter 2022 Operational Highlights 22% increase in sequential revenue growth since Q3 2021 through Q1 2022. 32% increase in professional services

    5/16/22 4:01:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    CynergisTek Will Host Conference Call on Monday, May 16, 2022, to Discuss First-Quarter 2022 Financial Results

    CynergisTek (NYSE:CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, today announced that management will host a conference call at 4:30 p.m. Eastern Time on Monday, May 16, 2022, to discuss first-quarter 2022 financial results. The results will be released prior to the call. Date: Monday, May 16, 2022 Time: 4:30 p.m. ET / 1:30 p.m. PT U.S.: 1-888-394-8218 International: 1-786-789-4776 Conference ID: 8001259 Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=W6CXE7Cj A replay of the call will be available from 7:30 p.m. ET on May 16, 2022 to 11:59 p.m.

    5/13/22 3:56:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology

    CynergisTek Reports Fourth Quarter and Full Year 2021 Financial Results

    CynergisTek, Inc. (NYSE:CTEK) (the "Company" or "CynergisTek"), a leader in cybersecurity, privacy, and compliance, today announced financial results for the three and twelve months ended December 31, 2021. Q4 and Full Year 2021 Operational Highlights 16% sequential revenue growth and 4% improvement to gross margins from Q3 to Q4 2021. 23% increase in bookings in the second half of the year when compared to the first. 15% increase of presold revenue to $20.0 million from Q1 to Q4 2021. 43 new customers added during the year. "Our focus in the second half of the year was on sales and operational improvements that would drive growth," said Mac McMillan, President and CEO of Cynergi

    3/24/22 4:01:00 PM ET
    $CTEK
    Retail: Computer Software & Peripheral Equipment
    Technology